What is Fosrenol ?

Lanthanum carbonate is a phosphate binder used primarily in the management of hyperphosphatemia in patients with chronic kidney disease (CKD), particularly those undergoing dialysis. It works by binding dietary phosphate in the gastrointestinal tract, thereby reducing serum phosphate levels and helping to prevent complications such as renal osteodystrophy. This compound is administered orally and is typically available in chewable tablet form, aiding in patient compliance.

• Nausea
• Vomiting
• Diarrhea
• Stomach pain
• Constipation
• Headache
• Fatigue
• Itching or rash

• Lanthanum carbonate should be used with caution in patients with gastrointestinal obstruction, ileus, or fecal impaction as it may worsen the condition.
• Patients with renal impairment should be monitored closely, as they may be at risk for increased systemic exposure.
• Avoid use in patients with severe hepatic impairment due to lack of safety data.
• Monitor serum calcium levels regularly, as lanthanum carbonate may affect calcium levels.
• Not recommended for use in children, as safety and effectiveness have not been established.
• Patients should inform their healthcare provider about any other medications they are taking, as lanthanum carbonate can interact with certain drugs.
• Seek medical attention immediately if experiencing symptoms of an allergic reaction, such as swelling of the face, lips, or tongue, or difficulty breathing.